Information:
Error:
Keywords
Lung Neoplasms ×
- Clinical Trial (298)
- Eligibility Determination (59)
- Treatment Form (45)
- Follow-Up Studies (45)
- Pulmonary Medicine (35)
- Registration (22)
- On-Study Form (22)
- Quality of Life (19)
- Laboratories (14)
- Baseline (12)
- Medical Oncology (12)
- Topotecan (11)
- Adenocarcinoma (11)
- Adverse event (11)
- Pathology (10)
- Disease Response (9)
- Neoplasms (9)
- Outcome Assessment (Health Care) (8)
- Small Cell Lung Carcinoma (8)
- Off-Treatment (8)
- Carcinoma, Non-Small-Cell Lung (7)
- Scores & Instruments (7)
- Released Standard (7)
- Non Small Cell Lung Cancer (6)
- Radiotherapy (5)
- Concomitant Medication (4)
- Clinical Protocols (4)
- Toxicity Tests (3)
- Trial screening (3)
- Neoplasm Metastasis (3)
- Radiology (2)
- Urinalysis (2)
- Body Surface Area (2)
- Body Weight (2)
- Chemistry, Clinical (2)
- Vital Signs (2)
- Pre-Study Form (2)
- Surgical Reporting Form (2)
- Document Tracking (2)
- Demography (2)
- Electrocardiography (2)
- Hematology (2)
- Appendix (1)
- Physical Examination (1)
- Surgical Procedures, Operative (1)
- Survival (1)
- Therapeutics (1)
- Thymus Neoplasms (1)
- Biopsy (1)
- Clinical Trial, Phase II (1)
- Clinical Trial, Phase III (1)
- Neuroendocrine Tumors (1)
- Clinical Chemistry Tests (1)
- Breast Neoplasms (1)
- Carcinoma (1)
- Consolidation Chemotherapy (1)
- Epidemiological Monitoring (1)
- Symptom Assessment (1)
- Patient Outcome Assessment (1)
- Patient Reported Outcome (PRO) (1)
- Common Data Elements (CDE) (1)
- Patient information (1)
- Disease Status (1)
- Electrocardiogram (ECG) (1)
- Routine documentation (1)
- Cisplatin (1)
- Death (1)
- Decision Making (1)
- Disease (1)
- Drug Therapy (1)
- Etoposide (1)
- Hematologic Tests (1)
- Hospitals, University (1)
- Hypertension (1)
- Medical History Taking (1)
- Organization and Administration (1)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
313 Search results.
Itemgroups: Inclusion Criteria,Exclusion Criteria
Itemgroup: Criteria
Itemgroups: CRF Header,Form Administration,Lung: Vital Status,Lung: Disease Follow-Up Status,Lung: Notice of Progression/Site,Lung: Subsequent Non-Protocol Therapy,Lung: Notice of New Primary,Lung: Long-Term Toxicity,Comments
Itemgroups: CRF Header,Form Administration,Lung: Vital Status,Lung: Disease Follow-Up Status,Lung: Notice of Progression/Site,Lung: Subsequent Non-Protocol Therapy,Lung: Notice of New Primary,Lung: Long-Term Toxicity,Comments
Itemgroup: Criteria
Itemgroups: Header,Physical Well-Being,Additional Concerns
Itemgroups: MODULE 1,PRE-TREATMENT CHACTERISTICS,LYMPH NODE ASSESSMENT
Itemgroups: Administrative data,Degree of health,Baseline tumor factors,Treatment Factors,Treatment Variables,Acute complications of treatment,Survival,Quality of death
Itemgroups: RTOG clinical trial administrative data,Assessment of Chemotherapy,REPORT ALL CONTINUING OR NEW ADVERSE EVENTS
Itemgroup: Criteria
Itemgroup: Criteria
Itemgroups: Header,PRE-TREATMENT CHACTERISTICS,LYMPH NODE ASSESSMENT,Comments